Roches OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia

19th July 2017 Uncategorised 0

Roche

More: Roches OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia
Source: MDlinx